Connect with us

CBD

The Quest For Transparency In The CBD Wild West How The New Senate Bill Could Bring Order To The Chaos

Published

on

This article was originally published on Leafreport and appears here with permission.

CBD has generated an excitement that swept across the US and the world, much like the way American pioneers of cowboys crossed the western border in the midst of a landscape of lawlessness and rebellion.

Everyone seems to be looking for a panacea these days – and if it’s natural or herbal, so much the better. Among the superfoods, dietary supplements, and nutraceuticals competing in the health market, cannabidiol (CBD) stands out as a unique compound.

After the 2018 Farm Bill was passed, hemp CBD products spread throughout the United States. As a non-intoxicating cannabinoid with anxiety-relieving, anti-emetic, and seizure-suppressing properties, CBD has piqued the interest of researchers. Studies of CBD are increasing, with evidence suggesting that CBD possesses therapeutic properties that could benefit a number of different diseases and disorders. It has also established a solid fan base among consumers who swear by it as a sleep aid and anti-anxiety supplement.

However, any rapidly evolving emerging market requires rules and regulations to separate the snake oil from real business. As the popularity of CBD has increased and as CBD lines diversify and expand, consumers are increasingly vulnerable to inferior brands that promise – but don’t deliver – potency and quality.

Ironically, those who can potentially benefit the most from CBD are also most at risk. Inferior CBD can have devastating consequences for vulnerable populations such as the elderly or the chronically ill.

With the FDA still working out the details of the guidelines for trading and promoting CBD, CBD consumers need independent insight into this emerging market from reliable sources.

While people are thrilled with the real therapeutic promise of this cannabinoid, it is also unscrupulous manufacturers and retailers who see the potential to make money. CBD topicals, edibles, tinctures, balms, and capsules are exploding alongside CBD-infused niche beverages, foods, skin, pet, and hair care products, with many making unsubstantiated claims about wellness benefits. The global CBD market is projected to reach $ 3.5 billion in 2021 – but as industry reports from Leafreport have shown, many of these products fail to deliver on their performance or quality promises.

While the FDA is working hard to develop a regulatory framework, there are a number of factors that make it difficult to regulate the CBD space. For starters, CBD is a cross-category compound in many ways. It is a cannabinoid that is not intoxicating but is psychoactive. The FDA currently views CBD as a drug, or “active ingredient,” even though hemp (0.3% THC or less) is legal at the federal level, meaning its inclusion in food and beverages has regulatory complications. However, at this point in time, the FDA has approved only one CBD product – Epidiolex – for treating seizures in certain forms of epilepsy in children.

The FDA is currently refining its stance on CBD and examining the available research on its therapeutic benefits, side effect profile, long-term use, and dosage guidelines. Recently, the FDA took action against the illegal marketing of CBD products in food for the prevention or treatment of disease, or as a cure for certain health problems. However, until the FDA publishes final guidelines on retailing and using CBD, consumers will have to deal with CBD products (and their sometimes opaque claims) on their own.

While there is no clear regulation of CBD brands and products at the federal level, many brands are trying to run their own (voluntary) external potency and purity tests to show consumers that their products are transparent and live up to their promises. Third-party potency and purity tests are currently considered an independent measure of quality in this currently unregulated landscape – a trait Leafreport regularly reviews when reviewing CBD brands and products.

Finally, another aggravating factor adding to the current chaos in the CBD industry is the significant discrepancies between state and federal government regulations. While some states like California allow various CBD products to be available over-the-counter, other states like Idaho enforce far stricter rules on the use and sale of the cannabinoid. At the federal level, CBD made exclusively from hemp plants with a THC content of 0.3% or less is legal, but CBD made from cannabis plants is not. In summary, a patchwork of rules governs the sale and consumption of CBD and confuses consumers.

Taken together, the factors discussed above contribute to a chaotic industry where too often CBD users don’t get what they pay for. While it is understandable that the FDA is taking the time to review the available data on the safety and effectiveness of CBD, consumers now need guidance and reliable evidence.

The current instability and inconsistency between state and federal CBD regulations has created a sloppy patchwork of rules that can adversely affect both consumers and the industry as a whole.

The recent rollout of the Hemp Access and Consumer Safety Act of 2021 could be the linchpin bringing order to chaos. If passed, the bill would amend the Federal Food, Drugs and Cosmetics Act (FD&CA) and allow CBD made from hemp to be classified as a food and dietary supplement.

Currently, the FDA is viewing hemp-derived CBD as a drug. The regulatory framework surrounding the Federal Food, Drug, and Cosmetic Act (the FD&C Act) prevents the FDA from establishing clear regulatory frameworks for hemp and hemp-derived CBD when used as a food and dietary supplement. This landmark legislation would subject foods and dietary supplements containing hemp (and CBD) to all safeguards provided by the current FDA regulatory framework for food and dietary supplements.

Additionally, the bill would prioritize consumer safety and require that manufacturers comply with all existing federal regulations for products containing CBD and ensure that those products are properly labeled.

If this new law is passed, it could mean significant positive changes for both CBD users and companies in the field. Consumers would be assured of more standardized federal guidelines and regulations for the manufacture, use and sale of CBD, and subpar CBD brands and products would be systematically sorted out – which would speak of separating the wheat from the chaff.

Additionally, in the absence of federal regulation of hemp-based CBD, the industry is characterized by thousands of “smaller players” hurrying into the market. Many larger players have failed to enter the CBD room until the FDA has clarified their stance on CBD. If this law is passed, the introduction of larger, more mature companies in this area could help bring about more standardization and quality in CBD products.

The result? The changes introduced by this bill would result in more consistent and concise guidance and improved quality of CBD products at the national level: a change that can only benefit this fast-growing industry.

Find our content in Spanish at El Planteo:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

CBD

Pressure BioSciences Nanoemulsion Platform Will Bring More Effective, More Shelf-Stable CBD-Infused Beverages to the Market by End of 2021

Published

on

Image provided by Pixabay

CBD-infused beverages will soon be available to consumers worldwide thanks to the nanoemulsion-producing Ultra Shear Technology ™ (UST ™) platform developed by Print BioSciences, Inc (OTCQB: PBIO). With a projected average annual growth rate (CAGR) of 21.2% over the next 7 years, the CBD market is projected to become 13 billion stable, water-soluble versions of the CBD oil by 2028 to allow for more predictable dosing and degradation during the Reduce distribution and storage. That is exactly what the new UST platform from Pressure BioSciences (PBI) did. How it works and what it means for consumers.

Why consumers need a water-soluble version of CBD

CBD is an oil-soluble compound found in cannabis plants. When extracted from the plant, it has no psychoactive side effects, but still offers many of the mental and physical health benefits that cannabis is known for.

Researchers have found that CBD has the potential to manage anxiety, reduce stress, and even reduce the severity of psychotic symptoms in schizophrenic patients. It also shows potential as a powerful anti-inflammatory agent, making it possible to relieve muscle and joint pain, treat symptoms of rheumatoid arthritis, and prevent or slow the growth of cancer cells.

Most importantly, all of these potential benefits come with few or no adverse side effects, which sets CBD-based treatments apart from many of the existing standards of care for these conditions, which are often associated with unpleasant or even harmful side effects.

However, the incredible potential of CBD-based treatments and wellness products has yet to be fully realized. While vegetable oil versions of CBD are already on the market, these oil-based products are not well absorbed by the human body, making it difficult for consumers to take full advantage of the compound.

The World Health Organization estimates that only 6% of CBD oil is actually absorbed when ingested or applied topically. The rest goes through the body, unused and wasted. As a result, the dosage is difficult to predict and the potential health benefits of the cannabis derivative are reduced by the inability of the body to fully absorb the oil.

The story goes on

PBI’s UST platform is helping CBD oil reach its potential

While the search for a method to reliably and consistently convert CBD oil into a water-soluble product that is more easily absorbed has continued, researchers have had little luck so far. Dr. Christopher Hudalla, President and Chief Scientific Officer (CSO) at ProVerde Labs, which tests cannabis-derived materials, commented on the lack of availability of cannabis-based products that are both truly water-soluble and shelf-stable for long enough to be marketable.

ProVerde’s CSO stated, “The introduction of a new technology platform that can consistently produce the ultra-small droplet size nanoemulsions necessary for reliable shelf life of over 1 year, including resistance to freeze-thaw challenges, will be a be a critical turning point and an explosive growth opportunity in the CBD and cannabis product industries. “

This new technology is PBI’s UST platform, which uniquely combines extremely high pressures with intense shear forces to break down CBD oil into droplets so small that the human body can effectively absorb the medicinal compound contained in the oil at significantly higher rates .

In addition, the nano-sized droplets are small enough to withstand regrowth into larger droplets – a problem that leads to this separation and deposition that you see in other emulsions like salad dressings or nut butters. Even with repeated freezing and thawing, a tried and tested test to determine long-term stability, the nanoemulsions made with UST do not separate from PBI or do not decompose.

PBI’s innovative technology makes it possible to ship CBD-enriched beverages worldwide and store them for longer periods of time without fear of the product losing its potency and effectiveness. As a result, consumers will have access to more effective and precisely dosed CBD beverages than ever before. PBI is partnering with industry leaders in the food and beverage space to bring the groundbreaking new CBD infusions to market before the end of 2021.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not offer investment advice. All rights reserved.

Continue Reading

CBD

Study Suggests Hemp Extract Is An Effective Weight-Loss Aid

Published

on

A proprietary hemp extract shows promise as a supplement for promoting weight loss, according to a study funded by a grant from the National Institutes of Health. Data from the double-blind, placebo-controlled study showed that all 100 participants who took Nitro-V hemp extract daily lost weight and lost up to 22 pounds over 90 days. The minimum weight loss for those taking the supplement was 5 pounds, while 64% of participants in the placebo group either gained weight or saw no change.

The study participants who took the hemp extract, which is high in cannabidiol (CBD), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), and other cannabinoids, also showed improvements in other metabolic health metrics and important wellness indicators without changing their diet and exercise habits to change. Participants who took Nitro-V saw their body mass index (BMI) decrease an average of three points and lost an average of 2.4 inches from their waist measurements. On average, the study participants in the placebo group gained weight and saw that their BMI remained the same.

Cannabis (hemp) extract.

getty

Almost 75% of Americans are overweight

According to data from the CDC, more than 73% of adults 20 years or older in the United States are overweight or obese. The health risks associated with obesity can be serious and include heart disease, diabetes, and high blood pressure. Additional CDC data shows that between 2013 and 2016, more than 49% of American adults reported trying to lose weight in the past 12 months.

“Those working to lose weight and improve their overall health are looking for every benefit they can find to help them stick to their exercise and nutrition plans,” said Arthur Jaffee, CEO of Nitro-V manufacturer ECS Brands , in a press release. “Given the results of these studies, we believe that Nitro-V could be the tool to help many achieve their weight loss potential and feel better.”

To conduct the clinical study, which had not yet been published in a peer-reviewed journal, the researchers assembled a group of 125 subjects to participate in the research. A total of 100 participants received either one or two 50 mg servings of Nitro-V daily, the remaining 25 participants received a placebo. Study participants were not told that they were participating in a weight loss study and that they had not changed their diet or exercise habits.

At the beginning and end of the 90-day study period, participants visited the Mayo Clinic campus in Scottsdale, Arizona and completed standardized surveys on health determinants such as diet, appetite, anxiety, and pain. The researchers also monitored the subjects’ weight, BMI, waist circumference, and vital signs, and performed full blood tests to measure blood sugar, cholesterol, and organ health, as well as other diagnostic tests. A statistician analyzed the data collected during the study to identify trends and evaluate the importance of the results. The research was funded by a small business owned by the National Institutes of Health and conducted by a contract researcher with 20 years of experience in product safety studies.

Each softgel microcapsule serving of Nitro-V contains 50 mg of hemp extract with a combination of cannabinoids such as CBD, THCV and CBDV in an organic hemp seed oil base. The solvent-free hemp extract contains the full cannabinoid profile of the source plant, including less than 0.1% THC. Further processing increases the THCV and CBDV levels in the supplement.

The “thin cannabinoid”

Cannabinoids from cannabis, including hemp, act on the body’s endocannabinoid system, which helps maintain physiological, cognitive, and emotional stability. Research has shown that THCV can act as an effective appetite suppressant, which has earned it the nickname “thin cannabinoid”. Other studies have shown that THCV can also help regulate blood sugar levels. THCV also has anti-inflammatory and antispasmodic properties.

Nitro-V hemp extract softgels from ECS Brands.

Photo courtesy of ECS Brands

Jaffee notes that recent research has shown that CBD and THCV can affect lipid and glucose metabolism in animals, both important factors in maintaining a healthy weight. The study also found that CBD had several positive effects on hyperglycemia, largely due to its anti-inflammatory and antioxidant properties. Further evidence from animal studies shows that CBD modulates the cardiovascular response to stress, which plays a role in weight gain and loss. However, the link between CBDV and weight loss is “less direct,” he says.

“Research shows that CBDV is a powerful anti-inflammatory agent that can play a role in both appetite and weight,” Jaffee wrote in an email. “Reduced inflammation in the body helps optimize the performance of the metabolic organs, and fat cells themselves are metabolic organs. Inflamed fat cells do not work properly and can contribute to unhealthy weight gain. “

The Nitro-V study also showed several other changes in the health and well-being of the participants, including many with the potential to affect weight loss. Participants who used the supplement in the study showed a 61% reduction in hunger and had fewer food cravings. In addition, all 37 study participants who took Nitro-V and were classified as prediabetic had their blood sugar levels returned to normal by the end of the 90-day study. The subjects also reported less difficulty resisting food cravings and showed improvements in sleep, happiness, and anxiety. Research also showed that the hemp extract was well tolerated and safe, with blood tests showing that all safety and toxicity levels remained within healthy, normal ranges.

A hemp field in rural Belgium.

getty

While the study was designed to examine the effects of Nitro-V on weight loss, Jaffee says the data suggests the supplement may have other health and health benefits as well.

“The ultimate goal of the study was to identify the overarching power of the ECS system, and the results indicate effects beyond weight loss and appetite suppression,” he writes. “But as with all cannabinoid and ECS researchers today, we still have many unanswered questions about how interactions between cannabinoids and the ECS lead to health improvements.”

Continue Reading

CBD

Could CBD Oil Help with Nausea?

Published

on

When it comes to the CBD industry, misinformation is rampant. There are too many brands out there trying to make quick money in a phenomenally fast growing market. With a lot of money at stake, these companies are less concerned about what they can do for their customers and more concerned about their profit margins.

The benefits of CBD are known due to the relentless research of dedicated scientists. However, the actions of certain brands lead the general public to remain skeptical.

My advice is to avoid brands that claim that their CBD oil “treats” everything. Unless the cannabinoid is approved by the FDA for medical treatment, no brand is allowed to make any medical claims. However, there is no question that CBD is a potential life changer for many people, for example against nausea. Let’s find out more.

What is nausea?

It is usually classified as a stomach discomfort that makes you want to throw up. It affects a wide variety of people and can have a variety of causes. Common reasons for nausea are:

  • heartburn
  • GERD
  • An infection or a virus
  • Motion sickness
  • Extreme pain
  • Medication

It’s important to remember that nausea is not a disease in itself. Instead, it’s your body’s response to one of a number of conditions. Although it feels awful, nausea is often necessary for your body to fight off unwanted invaders.

Although there are several anti-nausea drugs on the market, there is evidence that CBD may be effective against nausea.

How could CBD help with nausea?

THC is the most common intoxicating cannabinoid found in marijuana. It’s also available in small quantities in hemp. THC is known to create a high, and it binds to endocannabinoid receptors in the brain and spinal cord.

CBD works on these receptors too, but in a different way. First of all, it doesn’t bind directly to the CB1 and CB2 receptors. This helps explain why it doesn’t induce an intoxicating high. CBD helps the body produce higher levels of endocannabinoids like anandamide.

What does the research say?

Currently, much of the research on CBD for nausea is based on people with cancer. Nausea and vomiting are common side effects of chemotherapy. A study published in 2016 examined how cannabinoids can regulate acute and anticipatory nausea. The researchers found that a combination of THC and CBD could provide some relief to cancer patients undergoing chemotherapy.

The American Cancer Society actually puts cannabinoids on its list of drugs to use to treat nausea and vomiting. It suggests that these compounds may be useful in cases where traditional anti-nausea medications are ineffective.

A 2011 review of animal studies also looked at how cannabinoids can regulate nausea and vomiting. The researchers found that CBD was potentially useful against nausea due to its interaction with serotonin receptors. Serotonin is a hormone that affects our mood, behavior, and wellbeing.

THC is potentially more effective at reducing the effects of nausea. However, it causes a high intoxication and is not legal in over a dozen US states. It’s also not legal in many countries around the world. Although CBD is not strictly legal in America, it is widely used and tolerated. It is also widely used around the world, with many nations specifically saying that it is legal.

What types of CBD should I use for nausea?

You will likely get more benefits from CBD for nausea by trying a full-spectrum product. This is because research suggests that the presence of THC might increase its anti-nausea effects. A full-spectrum CBD product contains dozens of compounds and terpenes. However, in the United States, it cannot contain more than 0.3% THC. In the UK, the maximum THC content is 0.2%.

When you feel sick, it makes sense to avoid anything that could make you feel like you are vomiting. While some people can tolerate edibles or oils, others cannot. CBD capsules are another option. They have no taste and are easy to swallow. You could try vaping CBD for a faster effect, but your stomach may not like it!

It also makes sense to start with a relatively low dose and work your way up. Start with 5-10 mg of CBD and increase it as needed.

Final thoughts on CBD for nausea

According to the research available, there is plenty of evidence that CBD could be effective against nausea. While most of the studies are on cancer patients recovering from chemotherapy, you may find that CBD works for your nausea. There are also many other potential benefits of CBD that are worth exploring.

When trying out CBD for nausea, you need to carefully consider your method of consumption. Buy a moderate amount first to see how you react. If you can handle it, you can buy more and possibly increase the amount you consume.

Image by unbekanntuserpanama from Pixabay

Continue Reading
Advertisement

Trending